home / stock / rexn / rexn short
Short Information | Rexahn Pharmaceuticals (NYSE:REXN)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 2,701,623 |
Total Actual Volume | 23,903,068 |
Short Trends | |
---|---|
Cover Days | 20 |
Short Days | 0 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 135,081 |
Average Short Percentage | 9.73% |
Is there a REXN Short Squeeze or Breakout about to happen?
See the REXN Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
02-12-2020 | $3.12 | $3.33 | $3.60 | $2.99 | 3,197,318 | 330,546 | 10.34% |
02-11-2020 | $2.43 | $3.66 | $4.26 | $2.20 | 20,117,418 | 2,293,772 | 11.4% |
02-10-2020 | $2.0443 | $2.0412 | $2.10 | $2.03 | 14,069 | 2,698 | 19.18% |
02-07-2020 | $2.01 | $2.02 | $2.064 | $2.01 | 11,227 | 309 | 2.75% |
02-06-2020 | $2.06 | $2.01 | $2.10 | $2.0003 | 18,604 | 301 | 1.62% |
02-04-2020 | $2.16 | $2.09 | $2.16 | $2.065 | 15,166 | 21 | 0.14% |
02-03-2020 | $2.0263 | $2.16 | $2.17 | $1.99 | 24,578 | 14 | 0.06% |
01-31-2020 | $2.01 | $2.05 | $2.09 | $2.01 | 7,635 | 1,872 | 24.52% |
01-30-2020 | $2.1729 | $2.0293 | $2.1729 | $2.02 | 16,247 | 1,023 | 6.3% |
01-29-2020 | $2.2165 | $2.1137 | $2.24 | $2.10 | 7,050 | 310 | 4.4% |
01-28-2020 | $2.1222 | $2.1302 | $2.23 | $2.10 | 22,915 | 200 | 0.87% |
01-24-2020 | $2.1045 | $2.13 | $2.1628 | $2.0804 | 9,589 | 504 | 5.26% |
01-23-2020 | $2.22 | $2.12 | $2.24 | $2.12 | 18,699 | 1,857 | 9.93% |
01-22-2020 | $2.30 | $2.25 | $2.3109 | $2.215 | 27,012 | 101 | 0.37% |
01-21-2020 | $2.26 | $2.30 | $2.32 | $2.1907 | 58,583 | 6,475 | 11.05% |
01-17-2020 | $2.32 | $2.31 | $2.37 | $2.27 | 45,833 | 4,421 | 9.65% |
01-16-2020 | $2.32 | $2.27 | $2.3382 | $2.1779 | 27,389 | 4,273 | 15.6% |
01-15-2020 | $2.1001 | $2.2448 | $2.35 | $2.1001 | 110,968 | 21,256 | 19.16% |
01-14-2020 | $2.13 | $2.15 | $2.2399 | $2.09 | 120,083 | 24,653 | 20.53% |
01-13-2020 | $2.15 | $2.0901 | $2.15 | $2.00 | 32,685 | 7,017 | 21.47% |
News, Short Squeeze, Breakout and More Instantly...
Rexahn Pharmaceuticals Company Name:
REXN Stock Symbol:
NYSE Market:
FARMINGTON HILLS, Mich., Nov. 10, 2020 (GLOBE NEWSWIRE) -- Ocuphire Pharma, Inc., a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing therapies for the treatment of several eye disorders, today announced that will participate in the H.C. Wainwrigh...
Merger completed with Rexahn Pharmace u ticals c reat ing a Nasdaq-listed Biopharmaceutical Company Focused on Advancing Ocuphire’s Late-Stage Clinical Pipeline of Ophthalmic Drug Candidates Trading under "OCUP" on the Nasdaq Capital Market to begin No...
ROCKVILLE, Md., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NASDAQ:REXN) (“Rexahn”) announced today that the merger transaction between Rexahn and Ocuphire Pharma, Inc. is expected to be effective shortly after 4:00 pm (EST) today, Thursday, November 5, 202...